Accuracy and feasibility of initiating real-time continuous glucose monitoring in noncritically ill hospitalized patients with type 2 diabetes

Table 1 Baseline characteristics of the study participants, mean ± SD or n (%) or median (interquartile range)

Baseline characteristics	n = 25
Age (years)	72.8 ± 11.6
Female sex	16 (64)
BMI (kg/m2)	23.6 ± 3.6
Comorbidities
Hypertension	20 (80)
Dyslipidemia	16 (64)
Cerebrovascular disease	5 (20)
Coronary artery disease	4 (16)
Diabetes medication
No medication	5 (20)
OHA	10 (40)
Insulin	7 (28)
Insulin with OHA	3 (12)
HbA1c (%)	10 ± 3.1
eGFR (mL/minute/1.73 m2)	37 (20, 69.5)
Steroid use	3 (12)
Total daily insulin dose before enrollment (U/kg/day)	0.5 (0.4, 0.7)
Respiratory support
No respiratory support	12 (48)
Oxygen cannula	6 (24)
HFNC	1 (4)
Mechanical ventilation	6 (24)
Organ failure
No organ failure	23 (92)
Kidney failure	2 (8)
NEWS2
0-4	17 (68)
5-6	5 (20)
≥ 7	3 (12)
Length of stay (days)	27 ± 22.3
Admission diagnosis
Infection	12 (48)
Stroke	5 (20)
Heart failure or myocardial infarction	4 (16)
Cancer	2 (8)
Diabetic ketoacidosis	2 (8)

BMI: Body mass index; OHA: Oral hypoglycemic agent; HbA1c: Glycated hemoglobin; eGFR: Estimated glomerular filtration rate; HFNC: High-flow nasal cannula; NEWS2: National Early Warning Score 2.